FIELD: medicine; pharmaceutics.
SUBSTANCE: invention refers to pharmacology and medicine, namely to use of 7-hydroxycoumarin derivative of general formula (I), having protonophore activity. R in formula (I) is a linear alkyl containing 6–15 carbon atoms.
EFFECT: stimulation of selective degradation of mitochondria in cells (mitophagy) by means of 7-hydroxycoumarin derivative of general formula (I).
3 cl, 5 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| MILD CATIONIC MITOCHONDRIAL UNCOUPLERS | 2010 |
|
RU2527519C2 |
| SUBSTITUTED CYANOPYRROLIDINES HAVING ACTIVITY OF USP30 INHIBITORS | 2020 |
|
RU2822680C1 |
| METHOD FOR STIMULATING MITOPHAGY AND AUTOPHAGY IN CELLS, METHOD FOR STIMULATING AUTOPHAGY OR MITOPHAGY FOR TREATING A CONDITION ASSOCIATED WITH MITOCHONDRIAL DYSFUNCTION | 2020 |
|
RU2765414C1 |
| LOW-TOXICITY AMINOPHOSPHONIUM SALTS HAVING ANTICANCER ACTIVITY, AND METHOD FOR PREPARING THEM | 2024 |
|
RU2836726C1 |
| VANILIN DERIVATIVES WITH ANTITUMOUR ACTIVITY | 2016 |
|
RU2624903C1 |
| BROMINE-CONTAINING STERICALLY HINDERED PHENOLS WITH ANTICANCER ACTIVITY | 2023 |
|
RU2822270C1 |
| 1-PROPYL-2-OXO-4-HYDROXYQUINOLINE-3-CARBOXYLIC ACID DIETHYLAMINOETHYLAMIDE HYDROCHLORIDE SHOWING ANESTHETIC, ANTIARRHYTHMIC, ANTIOXIDANT, ANTIMICROBIAL AND FUNGICIDAL ACTIVITY | 1990 |
|
RU1774624C |
| OXAZOLIDINONES BASED ON PYRIDOXINE DERIVATIVES, HAVING ANTIBACTERIAL ACTIVITY | 2024 |
|
RU2836570C1 |
| COMBINATION OF SIROSINGOPIN AND MITOCHONDRIAL INHIBITORS FOR TREATMENT OF CANCER AND FOR IMMUNOSUPPRESSION | 2012 |
|
RU2602937C2 |
| PYRIDOXINE DERIVATIVES WITH NONLINEAR OPTICAL PROPERTIES | 2012 |
|
RU2501801C1 |
